Developing a kit to diagnose and predict outcomes of brain injuries.
Cilia Biomarker Kit Development for Brain Injury Diagnosis and Prognosis.
This study is working on a new blood test that looks for certain proteins to help doctors better understand how serious a traumatic brain injury is and how well someone might recover, making it easier to provide the best care for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cian, INC. NIH-funded |
| Lab location | 1 site (Pewaukee, United States) |
| Project ID | NIH-11006498 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis and prognosis of traumatic brain injuries (TBI) by developing a biomarker kit that utilizes specific proteins found in blood. The approach involves analyzing ciliary proteins, which are sensitive to blood flow changes, alongside established neuronal and glial markers to enhance outcome predictions for TBI patients. By identifying these biomarkers, the research aims to provide more accurate assessments of brain injury severity and recovery potential, ultimately improving patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have experienced a traumatic brain injury.
Not a fit: Patients with brain injuries that are not classified as traumatic or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and better prognostic tools for patients with traumatic brain injuries.
How similar studies have performed: Previous research has shown promise in using biomarkers for TBI diagnosis, but the specific approach of combining ciliary proteins with existing markers is relatively novel.
Where this research is happening
Pewaukee, United States
- Cian, INC. — Pewaukee, United States (Active)
Researchers
- Principal investigator: Ramchandran, Ramani — Cian, INC.
- Study coordinator: Ramchandran, Ramani
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.